Weili Wang

Weili joined the University Bridge Fund in 2021. Prior to joining Atlantic Bridge, Weili was a Biotech Investment Fellow at M Ventures, the venture capital arm of Merck KGaA. Before entering the venture capital world, Weili gained experienced across roles in the University of Queensland Technology Transfer Office, KPMG, as well as in Independent Innovation Centres. Weili holds two Master's degrees in Molecular Biology & Technology and Innovation Management from University of Queensland.